PRTN3 and Obesity: In ACPA-positive RA, patients with obesity had a significantly higher DAS during the entire 5-year follow-up compared to normal weight patients (β0.43; 95% CI 0.23, 0.64; Fig. 1B, for raw data see Supplementary Fig. 2).